{
  "ptid_time": "130_S_2403_2011-09-30",
  "img_path": "/data/qiuhui/data/adni/images/130_S_2403/2011-09-30/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 36,753 mm³, 30.9% above the reference mean. With a Z-score of 0.71 (76.1th percentile), this represents normal volume ; hippocampal volume measures 5,943 mm³, 16.5% below the reference mean. With a Z-score of -1.51 (6.5th percentile), this represents moderate atrophy; whole brain volume measures 1,025,500 mm³, 5.2% above the reference mean. With a Z-score of 0.66 (74.4th percentile), this represents normal volume ; entorhinal cortex volume measures 2,923 mm³, 20.4% below the reference mean. With a Z-score of -1.25 (10.5th percentile), this represents mild atrophy; fusiform gyrus volume measures 18,124 mm³, 6.5% above the reference mean. With a Z-score of 0.59 (72.4th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,704 mm³, 2.4% below the reference mean. With a Z-score of -0.21 (41.7th percentile), this represents normal volume . ",
  "text_data": "Age is 79.1 years. Gender is Female. Education: 15 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 29.0. MoCA: 24.0. Logical Memory: 5.0. Laboratory findings: Cholesterol (High Performance): 116.00 (significant reduced). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.54 SUVR (profound elevated); Amyloid beta: 572.40 pg/mL (mild reduced); Total tau: 259.20 pg/mL (normal ); Phosphorylated tau: 24.66 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows moderate hippocampal atrophy (Z-score -1.51, 6.5th percentile) and mild entorhinal cortex atrophy (Z-score -1.25, 10.5th percentile), both key regions in Alzheimer's pathology. Despite normal MMSE (29), the MoCA (24) suggests mild cognitive impairment, supported by mildly reduced Aβ and profoundly elevated AV45 (indicating amyloid deposition).  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **High**  \n\n*(Note: The combination of structural atrophy in AD-vulnerable regions, borderline MoCA, and amyloid positivity strongly suggests MCI, likely due to Alzheimer’s pathology, despite the absence of APOE4.)*",
  "timestamp": "2025-07-26T14:37:52.934566"
}